Results 251 to 260 of about 249,886 (308)

Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy. [PDF]

open access: yesDrug Saf
Cohen EB   +12 more
europepmc   +1 more source

Immunomodulatory therapies in sepsis

Intensive Care Medicine, 2000
Despite advances in critical care medicine, mortality from sepsis in ICU patients remains high. In response to several infectious and non-infectious stimuli, monocytes/ macrophages release a number of mediators, including cytokines, involved in the proinflammatory response that underlies sepsis.
W J, Kox, T, Volk, S N, Kox, H D, Volk
openaire   +2 more sources

Immunomodulatory aspects of photodynamic therapy

Expert Opinion on Investigational Drugs, 1998
In its conventional form, photodynamic therapy (PDT) is a clinically effective technique with which to treat tumours accessible to visible light. PDT utilises light absorbing compounds which catalyse the generation of toxic oxygen species, to produce localised antitumour effects.
D W, Hunt, J G, Levy
openaire   +2 more sources

Immunomodulatory therapy in yeast infections

Expert Review of Anti-infective Therapy, 2007
Invasive yeast infections are a significant cause of morbidity and mortality in patients with defective immune response, such as those with cancer-related immunosuppression, organ transplantation or other immunodeficiencies, and neonates. Hospitalization in the intensive care unit may increase the risk for such infections.
Jorge, Garbino   +2 more
openaire   +2 more sources

Immunomodulatory Therapy in Uveitis

2015
Corticosteroids are the cornerstone of treating intraocular inflammation, but may be inadequate in controlling the disease, or related side effects preclude long-term treatment. Additional immunosuppressive drugs are used in these cases to augment the effect of corticosteroids and allow for their reduction to safe levels while maintaining control of ...
Oren, Tomkins-Netzer   +4 more
openaire   +2 more sources

Immunomodulatory therapy for severe influenza

Expert Review of Anti-infective Therapy, 2011
Influenza A virus is a significant cause of morbidity and mortality worldwide. Severe influenza is recognized as a clinical syndrome, characterized by hyperinduction of proinflammatory cytokine production, otherwise known as hypercytokinemia or a 'cytokine storm'.
Ilyse, Darwish   +2 more
openaire   +2 more sources

Immunomodulatory therapy

Veterinary Dermatology, 2004
In veterinary dermatology, the therapeutic approach to numerous diseases (e.g. hypersensitivity and autoimmunity) centres upon suppression of an overactive immune system. By contrast, in other situations such as infectious diseases and cancer, it may be desirable to enhance an ineffective immune response.
openaire   +1 more source

Home - About - Disclaimer - Privacy